Evidence map›Paper›PMID 37349618›Full record

ArticleInternal and emergency medicine2023

Improving prediction of COVID-19 mortality using machine learning in the Spanish SEMI-COVID-19 registry.

José-Manuel Casas-Rojo, Paula Sol Ventura, Juan Miguel Antón Santos, Aitor Ortiz de Latierro, José Carlos Arévalo-Lorido, Marc Mauri, Manuel Rubio-Rivas, Rocío González-Vega, Vicente Giner-Galvañ, Bárbara Otero Perpiñá and 16 more

Abstract read
PubMed Publisher
In one paragraph

Article in Internal and emergency medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

José-Manuel Casas-Rojo *Internal Medicine Department, Infanta Cristina University Hospital, Parla, 28981, Madrid, Spain.
Paula Sol Ventura *Department of Pediatric Endocrinology, Hospital HM Nens, HM Hospitales, 08009, Barcelona, Spain.
Juan Miguel Antón SantosInternal Medicine Department, Hospital Universitario Infanta Cristina. Parla, Madrid, Spain.
Aitor Ortiz de LatierroData Scientist, Kaizen AI, Barcelona, Spain.
José Carlos Arévalo-LoridoInternal Medicine Department, Complejo Hospitalario Universitario, Badajoz, Spain.
Marc MauriData Scientist, Kaizen AI, Barcelona, Spain.
Manuel Rubio-RivasInternal Medicine Department, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain.
Rocío González-VegaInternal Medicine Department, Hospital Costa del Sol, Marbella, Málaga, Spain.
Vicente Giner-GalvañInternal Medicine Department, Hospital Universitario San Juan. San Juan de Alicante, Alicante, Spain.
Bárbara Otero PerpiñáInternal Medicine Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Eva Fonseca-AizpuruInternal Medicine Department, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain.
Antonio MuiñoInternal Medicine Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Esther Del Corral-BeamonteClinical Medicine Department, Hospital Royo Villanova, Saragossa, Spain.
Ricardo Gómez-HuelgasInternal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Málaga, Spain.
Francisco Arnalich-FernándezInternal Medicine Department, Hospital Universitario La Paz- Cantoblanco, Madrid, Spain.
Mónica Llorente BarrioInternal Medicine Department, Hospital Universitario Miguel Servet, Saragossa, Spain.
Aresio Sancha-LloretInternal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain.
Isabel Rábago LoriteInternal Medicine Department, Hospital Universitario Infanta Sofía. San Sebastián de los Reyes, Madrid, Spain.
José Loureiro-AmigoInternal Medicine Department, Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain.
Santiago Pintos-MartínezInternal Medicine Department, Hospital Universitario de Sagunto, Puerto de Sagunto, Valencia, Spain.
Eva García-SardónInternal Medicine Department, Hospital Universitario de Cáceres, Cáceres, Spain.
Adrián Montaño-MartínezInternal Medicine Department, Hospital de Montilla, Córdoba, Spain.
María Gloria Rojano-RiveroInternal Medicine Department, Hospital Infanta Elena, Huelva, Spain.
José-Manuel Ramos-RincónClinical Medicine Department, Miguel Hernandez University of Elche, 03550, Alicante, Spain. jramosrincon@gmail.com.
Alejandro López-EscobarPediatrics Department, Clinical Research Unit, Hospital Universitario Vithas Madrid La Milagrosa, Fundación Vithas, Madrid, Spain. lopezea@vithas.es.ORCID 0000-0002-9052-1429
SEMI-COVID-19 Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is responsible for high mortality, but robust machine learning-based predictors of mortality are lacking. To generate a model for predicting mortality in patients hospitalized with COVID-19 using Gradient Boosting Decision Trees (GBDT). The Spanish SEMI-COVID-19 registry includes 24,514 pseudo-anonymized cases of patients hospitalized with COVID-19 from 1 February 2020 to 5 December 2021. This registry was used as a GBDT machine learning model, employing the CatBoost and BorutaShap classifier to select the most relevant indicators and generate a mortality prediction model by risk level, ranging from 0 to 1. The model was validated by separating patients according to admission date, using the period 1 February to 31 December 2020 (first and second waves, pre-vaccination period) for training, and 1 January to 30 November 2021 (vaccination period) for the test group. An ensemble of ten models with different random seeds was constructed, separating 80% of the patients for training and 20% from the end of the training period for cross-validation. The area under the receiver operating characteristics curve (AUC) was used as a performance metric. Clinical and laboratory data from 23,983 patients were analyzed. CatBoost mortality prediction models achieved an AUC performance of 84.76 (standard deviation 0.45) for patients in the test group (potentially vaccinated patients not included in model training) using 16 features. The performance of the 16-parameter GBDT model for predicting COVID-19 hospital mortality, although requiring a relatively large number of predictors, shows a high predictive capacity.

Indexed as

COVID-19Hospital MortalityHumansMachine LearningRegistriesCOVID-19Deep learningMachine learningMortalitySpain

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.